Organization · Venture Capital
Phyto Partners
Phyto Partners is a venture capital firm based in Boca Raton, Florida, focusing on investments in the cannabis industry and brain health sectors. The firm provides debt and equity capital to early-stage companies, emphasizing ancillary businesses that support licensed operators.
Overview
What Phyto Partners does
What Phyto Partners is
Phyto Partners is a venture capital firm based in Boca Raton, Florida, focusing on investments in the cannabis industry and brain health sectors. The firm provides debt and equity capital to early-stage companies, emphasizing ancillary businesses that support licensed operators.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Phyto Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Phyto Partners as a funder
Investment thesis
Phyto Partners focuses on investing in ancillary businesses within the cannabis industry and brain health, targeting early-stage operators with capital and strategic support.
Focus narrative
Phyto Partners invests in ancillary businesses within the cannabis industry, including sectors such as advertising technology, agriculture technology, biotechnology, brand building, cannabis delivery services, data, education, and software (SaaS). The firm seeks to provide business-critical solutions that help licensed operators comply with regulations, manage their businesses, connect with customers, build brands, and operate efficiently. The firm also has a psychedelic-focused fund, Phyto Psyche, which targets investments in the intersection of psychedelic medicine and science.
Value beyond capital
Phyto Partners adds value to its portfolio companies by providing strategic support, connecting them with resources, and leveraging a network across its portfolio to enhance operational efficiency and compliance.
Terms and economics
- Typical check
- $250,000–$2,000,000
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Angel · Accelerator
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Marijuana Doctor, Skylight Health, Agrify, and Greenlane
Portfolio context
Notable portfolio companies include: Marijuana Doctor: Exited in 2023. Agrify: Public listing in 2019. Skylight Health: Exited in 2019. Greenlane: Public listing in 2020. Other companies include Flowhub, LeafLink, Front Range Biosciences, Green Flower, Wurk, Vangst, and Fyllo.
Common questions
What to know about Phyto Partners
Upseed classifies Phyto Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.